drugset

drugset / Trial / NCT00638872

Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers

NCT00638872 ↗

Phase 4 Completed 215 enrolled University of Messina

RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of the study is to evaluate the efficacy of the polydeoxyribonucleotide in improving the healing of diabetic foot ulcers.

Timeline

Start: 2007-10
Primary completion: 2010-12
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Polydeoxyribonucleotide	Unknown	—	Other

Indications